Back to search

Article

Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

2022-01-17

Abstract excerpt

<h4>Background: </h4> Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adherence, and healthcare resource utilization (HRU) and costs in individuals with schizophrenia overall and by CTO status before and after second generation antipsycho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8292f10-b932-5889-9382-9518f3dcfdb4
DOI
10.21203/rs.3.rs-1254661/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studyDOI 10.21203/rs.3.rs-1254661/v1
Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatmentSemantic proximity
PS1-37: Comparison of Antipsychotic Polypharmacy Trends among Schizophrenia Patients across Multiple Healthcare SystemsSemantic proximity
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in SwitzerlandSemantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisationSemantic proximity
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness studySemantic proximity
Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort StudySemantic proximity
The impact of recreational cannabis legalization on cannabis-related acute care events among adults with schizophreniaSemantic proximity
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable AntipsychoticsSemantic proximity
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoverySemantic proximity
Application of a Medication Adherence Management Program Based on the Cox-Interaction Model of Client Health Behavior in Patients with SchizophreniaSemantic proximity
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studySemantic proximity
Select a neighboring publication to make it the new centre.